Genetic Testing in Breast Cancer: Innovations in Diagnosis and Treatment addresses the urgent need for novel, minimally invasive diagnostic techniques to accurately identify breast cancer early and monitor treatment efficacy, focusing particularly on triple-negative breast cancer (TNBC). This comprehensive volume analyzes the latest research and developments in genetic testing, covering strategies like next-generation sequencing and the Sanger method. It highlights their potential to revolutionize early diagnosis and personalized treatment plans. The book also discusses challenges and opportunities, providing insights into hereditary mutations, genetic counseling, and clinical practice integration.

Serving as a valuable resource for students, researchers, oncologists, pharmacologists, and healthcare professionals, it includes preclinical and clinical case studies that illustrate the practical applications of genetic testing for various breast cancer subtypes, including TNBC and HER2-positive breast cancer. The editors aim to advance treatment and improve patient outcomes through cutting-edge genetic testing techniques.

• Explores the latest genetic testing strategies, including next-generation sequencing and the Sanger method for early and accurate breast cancer diagnosis and treatment
• Includes practical preclinical and clinical case studies that demonstrate the application of genetic testing for various breast cancer subtypes, such as TNBC and HER2-positive breast cancer
• Provides in-depth insights into the challenges and opportunities in integrating genetic testing into clinical practice, with a focus on personalized treatment plans